Synthesis of Mimetics of Natural Compounds in Drug Development
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 346
Special Issue Editors
Interests: chemical thermodynamics; differential scanning calorimetry (DSC); physico-chemical characterization of the API; binary mixtures of API; SLE phase diagrams; pseudopolymorphism; dissolution studies
Interests: alginate; cellulose; collagen; keratin; biopolymers; gamma irradiation; functionalisation; natural polymers; biosorbent; advanced materials
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The synthesis of compounds that mimic the behaviour of natural compounds that have the same beneficial properties for the body is a very interesting and challenging field. Researchers around the world play an important role, especially in the pharmaceutical field, in the discovery of new compounds that can be used in drug development. The synthesis, characterization and behaviour of mimetic compounds is an area of research that is constantly growing and yielding important results, but there is still much to be done. Modern synthetic techniques can be applied to synthesize completely new active materials and molecules that mimic natural compounds. The purpose of this Special Issue is to focus on the synthesis and characterization of mimetics of natural compounds and their potential uses in drug development.
Dr. Elena Pincu
Dr. Ioana Stanculescu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mimetic compounds
- drug development
- synthesis techniques
- chemical characterization
- therapeutic potential of mimetic compounds
- new drugs that mimic natural compounds
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
